{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:58:07Z","timestamp":1787018287974,"version":"build-2736575974"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1117728"],"award-info":[{"award-number":["OPP1117728"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M011569\/1"],"award-info":[{"award-number":["MR\/M011569\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N016874\/1"],"award-info":[{"award-number":["MR\/N016874\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1117728"],"award-info":[{"award-number":["OPP1117728"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M011569\/1"],"award-info":[{"award-number":["MR\/M011569\/1"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N016874\/1"],"award-info":[{"award-number":["MR\/N016874\/1"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Pneumococcal pneumonia remains a global health problem. Pneumococcal colonization increases local and systemic protective immunity, suggesting that nasal administration of live attenuated Streptococcus pneumoniae (Spn) strains could help prevent infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We used a controlled human infection model to investigate whether nasopharyngeal colonization with attenuated S. pneumoniae strains protected against recolonization with wild-type (WT) Spn (SpnWT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Healthy adults aged 18\u201350\u2009years were randomized (1:1:1:1) for nasal administration twice (at a 2-wk interval) with saline solution, WT Spn6B (BHN418), or one of two genetically modified Spn6B strains, SpnA1 (\u0394fhs\/piaA) or SpnA3 (\u0394proABC\/piaA) (Stage I). After 6\u2009months, participants were challenged with SpnWT to assess protection against the homologous serotype (Stage II).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>125 participants completed both study stages per intention to treat. No serious adverse events were reported. In Stage I, colonization rates were similar among groups: SpnWT, 58.1% (18 of 31); SpnA1, 60% (18 of 30); and SpnA3, 59.4% (19 of 32). Anti-Spn nasal IgG levels after colonization were similar in all groups, whereas serum IgG responses were higher in the SpnWT and SpnA1 groups than in the SpnA3 group. In colonized individuals, increases in IgG responses were identified against 197 Spn protein antigens and serotype 6 capsular polysaccharide using a pangenome array. Participants given SpnWT or SpnA1 in Stage I were partially protected against homologous challenge with SpnWT (29% and 30% recolonization rates, respectively) at stage II, whereas those exposed to SpnA3 achieved a recolonization rate similar to that in the control group (50% vs. 47%, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Nasal colonization with genetically modified live attenuated Spn was safe and induced protection against recolonization, suggesting that nasal administration of live attenuated Spn could be an effective strategy for preventing pneumococcal infections.<\/jats:p>\n                    <jats:p>Clinical trial registered with the ISRCTN registry (ISRCTN22467293).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.202302-0222oc","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T14:47:11Z","timestamp":1691592431000},"page":"868-878","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":17,"title":["A Randomized Controlled Clinical Trial of Nasal Immunization with Live Virulence Attenuated\n                    <i>Streptococcus pneumoniae<\/i>\n                    Strains Using Human Infection Challenge"],"prefix":"10.1093","volume":"208","author":[{"given":"Helen","family":"Hill","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7586-6050","authenticated-orcid":false,"given":"Elena","family":"Mitsi","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissavet","family":"Nikolaou","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Blizard","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherin","family":"Pojar","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hyder-Wright","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Devin","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Rein\u00e9","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0871-4780","authenticated-orcid":false,"given":"Ryan","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Sol\u00f3rzano","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4835-1032","authenticated-orcid":false,"given":"Simon P.","family":"Jochems","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinashe","family":"Kenny-Nyazika","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0803-2755","authenticated-orcid":false,"given":"Elisa","family":"Ramos-Sevillano","sequence":"additional","affiliation":[{"name":"UCL Respiratory, Division of Medicine, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Weight","sequence":"additional","affiliation":[{"name":"Division of Infection and Immunity, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Myerscough","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"McLenaghan","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6164-2854","authenticated-orcid":false,"given":"Ben","family":"Morton","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Gibbons","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madlen","family":"Farrar","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Randles","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Burhan","sequence":"additional","affiliation":[{"name":"Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"Shandling","sequence":"additional","affiliation":[{"name":"Antigen Discovery Inc, Irvine, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe J.","family":"Campo","sequence":"additional","affiliation":[{"name":"Antigen Discovery Inc, Irvine, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4573-449X","authenticated-orcid":false,"given":"Robert S.","family":"Heyderman","sequence":"additional","affiliation":[{"name":"Division of Infection and Immunity, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Malawi Liverpool Wellcome-Trust Programme, Blantyre, Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy S.","family":"Brown","sequence":"additional","affiliation":[{"name":"UCL Respiratory, Division of Medicine, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Liverpool University Hospitals National Health Service Foundation Trust, Liverpool, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela M.","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom"},{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,15]]},"reference":[{"key":"2026012204382418400_bib1","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000-15","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2026012204382418400_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/14760584.2017.1393335","article-title":"Pneumococcal whole-cell and protein-based vaccines: changing the paradigm","volume":"16","author":"Pichichero","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"2026012204382418400_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jinf.2005.02.008","article-title":"The current burden of pneumococcal disease in England and Wales","volume":"52","author":"Melegaro","year":"2006","journal-title":"J Infect"},{"key":"2026012204382418400_bib4","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/thoraxjnl-2012-201924","article-title":"Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD","volume":"67","author":"Garcha","year":"2012","journal-title":"Thorax"},{"key":"2026012204382418400_bib5","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"2013","author":"Moberley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012204382418400_bib6","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/S1473-3099(18)30660-1","article-title":"Making sense of differences in pneumococcal serotype replacement","volume":"19","author":"Lewnard","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2026012204382418400_bib7","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2026012204382418400_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"2026012204382418400_bib9","doi-asserted-by":"crossref","first-page":"e0177113","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS One"},{"key":"2026012204382418400_bib10","doi-asserted-by":"crossref","first-page":"e02097-17","DOI":"10.1128\/mBio.02097-17","article-title":"Mucosal infections and invasive potential of nonencapsulated Streptococcus pneumoniae are enhanced by oligopeptide binding proteins AliC and AliD","volume":"9","author":"Bradshaw","year":"2018","journal-title":"mBio"},{"key":"2026012204382418400_bib11","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.vaccine.2013.03.013","article-title":"Lack of cross-protection against invasive pneumonia caused by heterologous strains following murine Streptococcus pneumoniae nasopharyngeal colonisation despite whole cell ELISAs showing significant cross-reactive IgG","volume":"31","author":"Cohen","year":"2013","journal-title":"Vaccine"},{"key":"2026012204382418400_bib12","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.vaccine.2012.04.080","article-title":"Contributions of capsule, lipoproteins and duration of colonisation towards the protective immunity of prior Streptococcus pneumoniae nasopharyngeal colonisation","volume":"30","author":"Cohen","year":"2012","journal-title":"Vaccine"},{"key":"2026012204382418400_bib13","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1128\/IAI.01972-06","article-title":"Live attenuated Streptococcus pneumoniae strains induce serotype-independent mucosal and systemic protection in mice","volume":"75","author":"Roche","year":"2007","journal-title":"Infect Immun"},{"key":"2026012204382418400_bib14","doi-asserted-by":"crossref","first-page":"e1002622","DOI":"10.1371\/journal.ppat.1002622","article-title":"Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage","volume":"8","author":"Wright","year":"2012","journal-title":"PLoS Pathog"},{"key":"2026012204382418400_bib15","doi-asserted-by":"crossref","first-page":"e1003274","DOI":"10.1371\/journal.ppat.1003274","article-title":"Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung","volume":"9","author":"Wright","year":"2013","journal-title":"PLoS Pathog"},{"key":"2026012204382418400_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/imcb.12257","article-title":"Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine","volume":"97","author":"David","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"2026012204382418400_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20011576","article-title":"The immune response to pneumococcal proteins during experimental human carriage","volume":"195","author":"McCool","year":"2002","journal-title":"J Exp Med"},{"key":"2026012204382418400_bib18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mi.2014.95","article-title":"Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses","volume":"8","author":"Wilson","year":"2015","journal-title":"Mucosal Immunol"},{"key":"2026012204382418400_bib19","doi-asserted-by":"crossref","first-page":"e1002396","DOI":"10.1371\/journal.ppat.1002396","article-title":"Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue","volume":"7","author":"Pido-Lopez","year":"2011","journal-title":"PLoS Pathog"},{"key":"2026012204382418400_bib20","first-page":"1899","article-title":"Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice","volume":"119","author":"Zhang","year":"2009","journal-title":"J Clin Invest"},{"key":"2026012204382418400_bib21","doi-asserted-by":"crossref","first-page":"e25558","DOI":"10.1371\/journal.pone.0025558","article-title":"Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation","volume":"6","author":"Cohen","year":"2011","journal-title":"PLoS One"},{"key":"2026012204382418400_bib22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1164\/rccm.201212-2277OC","article-title":"Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults","volume":"187","author":"Ferreira","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204382418400_bib23","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1172\/JCI128865","article-title":"Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization","volume":"129","author":"Jochems","year":"2019","journal-title":"J Clin Invest"},{"key":"2026012204382418400_bib24","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1164\/rccm.202011-4161LE","article-title":"Preclinical development of virulence-attenuated Streptococcus pneumoniae strains able to enhance protective immunity against pneumococcal infection","volume":"203","author":"Ramos-Sevillano","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204382418400_bib25","doi-asserted-by":"crossref","first-page":"e931","DOI":"10.1016\/S2666-5247(22)00283-X","article-title":"Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial","volume":"3","author":"Dale","year":"2022","journal-title":"Lancet Microbe"},{"key":"2026012204382418400_bib26","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1093\/cid\/civ098","article-title":"Nasal inoculation of the commensal Neisseria lactamica inhibits carriage of neisseria meningitidis by young adults: a controlled human infection study","volume":"60","author":"Deasy","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026012204382418400_bib27","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41590-018-0231-y","article-title":"Inflammation induced by influenza virus impairs human innate immune control of pneumococcus","volume":"19","author":"Jochems","year":"2018","journal-title":"Nat Immunol"},{"key":"2026012204382418400_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/mi.2016.71","article-title":"Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage","volume":"10","author":"Mitsi","year":"2017","journal-title":"Mucosal Immunol"},{"key":"2026012204382418400_bib29","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1164\/rccm.201512-2467OC","article-title":"Polysaccharide-specific memory B cells predict protection against experimental human pneumococcal carriage","volume":"194","author":"Pennington","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204382418400_bib30","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1164\/rccm.202112-2700OC","article-title":"Human infection challenge with serotype 3 pneumococcus","volume":"206","author":"Robinson","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204382418400_bib31","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.vaccine.2019.05.080","article-title":"Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density","volume":"37","author":"German","year":"2019","journal-title":"Vaccine"},{"key":"2026012204382418400_bib32","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/rccm.201503-0542OC","article-title":"First human challenge testing of a pneumococcal vaccine. Double-blind randomized controlled trial","volume":"192","author":"Collins","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204382418400_bib33","first-page":"50115","article-title":"Experimental human pneumococcal carriage","author":"Gritzfeld","year":"2013","journal-title":"J Vis Exp"},{"key":"2026012204382418400_bib34","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ng.2625","article-title":"Population genomics of post-vaccine changes in pneumococcal epidemiology","volume":"45","author":"Croucher","year":"2013","journal-title":"Nat Genet"},{"key":"2026012204382418400_bib35","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1073\/pnas.1613937114","article-title":"Diverse evolutionary patterns of pneumococcal antigens identified by pangenome-wide immunological screening","volume":"114","author":"Croucher","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012204382418400_bib36","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behav Brain Res"},{"key":"2026012204382418400_bib37","doi-asserted-by":"crossref","first-page":"e1006137","DOI":"10.1371\/journal.ppat.1006137","article-title":"Naturally acquired human immunity to pneumococcus is dependent on antibody to protein antigens","volume":"13","author":"Wilson","year":"2017","journal-title":"PLoS Pathog"},{"key":"2026012204382418400_bib38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1164\/rccm.201910-2047ED","article-title":"Improving pulmonary immunity to bacterial pathogens through Streptococcus pneumoniae colonization of the nasopharynx","volume":"201","author":"Brown","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012204382418400_bib39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1164\/rccm.201903-0607OC","article-title":"Nasal pneumococcal density is associated with microaspiration and heightened human alveolar macrophage responsiveness to bacterial pathogens","volume":"201","author":"Mitsi","year":"2020","journal-title":"Am J Respir Crit Care Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/208\/8\/868\/66432445\/ajrccm_208_8_868.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/208\/8\/868\/66432445\/ajrccm_208_8_868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:38:41Z","timestamp":1769074721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/208\/8\/868\/8426753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,10,15]]},"published-print":{"date-parts":[[2023,10,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202302-0222oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"2023-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}